Race Oncology Ltd. (AU:RAC) has released an update.
Race Oncology Ltd has announced its application for the quotation of new securities on the ASX, with the issue date set for August 1, 2024. A total of 408 ordinary fully paid shares under the code RAC are set to be quoted. This move signifies the company’s compliance with the ASX Listing Rules and its continued advancement within the pharmaceutical sector.
For further insights into AU:RAC stock, check out TipRanks’ Stock Analysis page.
